Join former FDA advertising and promotion leader Glenn N. Byrd as he explores advertising and promotion of pharmaceutical and biotech products in the regulatory environment. This webcast offers insight into hot topics including: analyzing and dissecting recent FDA guidances on social media and analyzing recent FDA enforcement actions.
Santa Clara, CA1/10/2015 - 3/7/2015
Improve how effectively you network and advocate for yourself with ideas and techniques from this on-demand webcast.
Local or global—RAPS has you covered with offices in Washington, DC, Shanghai and Singapore. There are RAPS chapters in Canada, Israel, Switzerland, Taiwan and throughout the United States, and local networks in Australia, Belgium, Brazil, Germany, India, Mexico, The Netherlands, Poland and Singapore.
Placeholder for Higher Logic Forum Discussions - DO NOT DELETE
How regulatory professionals can apply the RAPS Code of Ethics to
current and future endemic disease outbreaks characterized by a rapidly
developing healthcare situation and quickly evolving knowledge base
regarding prevention, treatment and potential cures.
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Regulatory Focus is pleased to offer this webpage as a way to keep track of legislation—both passed and proposed—intending to affect areas regulated by FDA. We intend to update this webpage regularly, so please check back often.
The US Food and Drug Administration's patient-focused drug development program is poised to overhaul how drugs are approved for rare and inadequately served diseases and conditions. This tracker provides an in-depth look at what questions FDA is asking of patients and their representatives.